BioSpace News Archive

Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that management will present at two investor conferences in October.

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 2:25 p.m. EDT on Thursday, October 3, at the Cantor Global Healthcare Conference.

cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), has signed a comprehensive, multi-year Partnership agreement with Life Time to bring CBD awareness and education to millions of Americans coast-to-coast.

A sterile barrier dressing can improve patient safety while lowering costs up to 67 percent, when used as part of a standardized process for placing ultrasound-guided peripheral IV (UGPIV) catheters, according to a new study from PICC Excellence and Sharp HealthCare (San Diego)

Bain & Company research shows more than 50 percent of all outpatient procedures in the US are performed at ASCs, with expected growth of 6-7 percent a year through 2021

Thermo Fisher Scientific today unveiled the next-generation Thermo Scientific DXR3 Family of Raman Spectrometers and Microscopes

More than one in four heart attack survivors don’t completely understand the role aspirin plays in helping prevent a second heart attack – and among those not currently taking aspirin, nearly one in five say it is because they saw a news article that made them feel they should not take aspirin, contrary to current medical guidelines.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, announced today that it has named Andrew A. Komjathy as Chief Commercial Officer.

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced its participation in the following upcoming investor conferences

Vital Metrix, Inc. today announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has selected the company as the winner of its “Best Biometric Sensor Solution” award in the 2019 MedTech Breakthrough Awards program.